Tagadtal, Husain M.

HRN: 21-51-02  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/24/2022
CEFUROXIME 1.5GM (VIAL)
06/24/2022
06/30/2022
IVTT
1.5
Q8
TB Spondylodiscitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: